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ABSTRACT Steady-state and time-resolved fluorescence spectroscopy was used to follow the local and global changes in
structure and dynamics during chemical and thermal denaturation of unlabeled human serum albumin (HSA) and HSA with
an acrylodan moiety bound to Cys34. Acrylodan fluorescence was monitored to obtain information about unfolding processes
in domain I, and the emission of the Trp residue at position 214 was used to examine domain II. In addition, Trp-to-acrylodan
resonance energy transfer was examined to probe interdomain spatial relationships during unfolding. Increasing the tem-
perature to less than 50°C or adding less than 1.0 M GdHCl resulted in an initial, reversible separation of domains I and II.
Denaturation by heating to 70°C or by adding 2.0 M GdHCl resulted in irreversible unfolding of domain II. Further denaturation
of HSA by either method resulted in irreversible unfolding of domain I. These results clearly demonstrate that HSA unfolds by
a pathway involving at least three distinct steps. The low detection limits and high information content of dual probe
fluorescence should allow this technique to be used to study the unfolding behavior of entrapped or immobilized HSA.
INTRODUCTION
Human serum albumin (HSA) is a large protein that is
formed from a single polypeptide chain of 585 residues
(Carter and Ho, 1994). The structure is divided into three
major domains, and contains a total of 17 disulfide bonds
(Brown, 1977). Despite the size and complexity of HSA,
there is only a single Trp residue within the protein at
position 214 in domain II (Carter and Ho, 1994). In addi-
tion, the protein contains only one free Cys residue at
position 34 in domain I (Brown, 1977). The presence of the
free thiol allows for site-specific labeling of the protein with
chromophoric or fluorescent probes (Suzukida et al., 1983;
Hagag et al., 1983; Ingersoll et al., 1996; Jordon et al., 1995;
Wang et al., 1996; Narazaki et al, 1997; Lundgren et al.,
1995).
HSA is the most abundant human blood protein and has
the ability to bind several ligands, including small aromatic
and heterocyclic carboxylic acids, such as the nonsteroidal
antiinflammatory drugs (NSAIDs) (Sudlow et al., 1976).
The ability of HSA to bind multiple ligands, combined with
the size and complexity of the protein structure (which is in
some ways reminiscent of enzymes and antibodies), has
resulted in the protein becoming a popular model system for
studies of immobilized or entrapped biorecognition ele-
ments that are employed in biosensor devices (Ingersoll et
al., 1996; Jordon et al., 1995; Wang et al., 1996; Narazaki et
al., 1997; Lundgren et al., 1995). Both unlabeled HSA and
HSA labeled with the fluorescent probe acrylodan at Cys34
have been examined in solution and when immobilized to
inorganic surfaces (Ingersoll et al., 1996; Jordon et al.,
1995; Wang et al., 1996; Narazaki et al., 1997; Lundgren et
al., 1995). The acrylodan probe was chosen for these studies
because it is sensitive to the local environmental dipolarity
and dynamics within the binding pocket surrounding Cys34
(Lundgren et al., 1995; Prendergast et al., 1983; Ilich and
Prendergast, 1989; Clark and Burtnick, 1988; Yem et al.,
1992). The acrylodan probe allowed the structure and dy-
namics of acrylodan-labeled HSA (HSA-Ac) to be exam-
ined, and allowed factors such as the accessibility of the
reporter group to be monitored (Suzukida et al., 1983;
Hagag et al., 1983; Ingersoll et al., 1996; Jordon et al.,
1995).
One of the issues that is of interest for both free and
immobilized proteins is the retention of protein function and
how this relates to changes in the protein structure. This
becomes especially important when one desires information
on the effects of different encapsulation or immobilization
protocols on protein structure and/or function. Several stud-
ies have appeared that have examined the structure, stabil-
ity, and unfolding pathway of unlabeled HSA in solution
(Pico, 1995, 1996, 1997; Wetzel et al., 1980; Tayyab et al.,
1995; Lee and Hirose, 1992; Wallevik, 1973; Farruggia et
al., 1997; Chmelik and Kalous, 1982). A variety of tech-
niques have been applied, including NMR (Price et al.,
1993), circular dichroism (Wetzel et al., 1980), differential
scanning calorimetry (Pico, 1995, 1996, 1997), and mea-
surement of intrinsic fluorescence (Pico, 1995; Farruggia et
al., 1997). In addition, there is a recent report in which the
steady-state and time-resolved fluorescence of the acrylo-
dan label has been monitored during chemical denaturation
of HSA-Ac in solution (Narazaki et al., 1997). Unfortu-
nately, most of these techniques, with the exception of
fluorescence spectroscopy, are not amenable to studies of
entrapped or immobilized proteins. Furthermore, the infor-
mation that is normally obtained from fluorescence studies
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is often not sufficient to characterize subtle changes in the
structure of large proteins. It is important to recognize that
no studies have appeared that comprehensively describe the
fluorescence behavior of both labeled and unlabelled HSA
and how the fluorescence is affected by changes in structure
and dynamics that are caused by thermally and chemically
denaturing the protein.
In the present work, the emission of the acrylodan moiety
attached at Cys34 is used to provide information on the local
structure and dynamics of domain I, and the fluorescence of
the single Trp residue is used to provide information on the
local structure and dynamics of domain II during thermal
and chemical denaturation. We report a detailed investiga-
tion of the steady-state fluorescence, steady-state anisot-
ropy, and time-resolved fluorescence behavior of both Trp
and acrylodan. Such studies provide a large amount of
information, including local polarity, dynamics, and probe
accessibility from two locations within the protein. In ad-
dition, we show here for the first time that the monitoring of
Trp fluorescence from HSA-Ac provides the ability to in-
vestigate the spatial relationship between the Trp and acry-
lodan probes by resonance energy transfer techniques, ow-
ing to the overlap of the acrylodan excitation spectrum and
the Trp emission spectrum. HSA has previously been la-
beled at the Cys residue for the purpose of examining
interdomain spacings via energy transfer (Suzukida et al.,
1983; Hagag et al., 1983). However, in this previous work
only the effects of pH-induced structural alterations on the
energy transfer efficiency were examined. Unfolding stud-
ies were not done with the labeled protein. In the present
work, energy transfer measurements are used to provide a
convenient method for examining changes in interdomain
distances during denaturation and refolding, providing in-
formation on the spatial relationships between domains I
and II.
The reversibility of unfolding at different stages and its
correlation to protein function are also examined via bind-
ing of the fluorescent ligand salicylate (Brown and Crooks,
1976; Kerestes-Nagy et al., 1972; Hultmark et al., 1975).
Salicylate binding studies provide information on the rela-
tionship between protein structure and function. By com-
bining all of the fluorescence and binding data, we have
been able to elucidate subtle features of the protein unfold-
ing pathway that are not easily observed by other methods.
These observations provide the key groundwork for future
studies involving entrapped HSA and HSA-Ac.
MATERIALS AND METHODS
Materials
HSA (essentially fatty acid free), sodium salicylate, N-acetyltryptophan-
amide (NATA), and 3500 MW cutoff dialysis tubing were obtained from
Sigma (St. Louis, MO). 6-Acryloyl-2-(dimethylamino)naphthalene (acry-
lodan) was obtained from Molecular Probes (Eugene, OR). 1,4-Bis(4-
methyl-5-phenyl-2-oxazolyl)benzene (Me2-POPOP), acrylamide (99%),
and sodium azide (99%) were supplied by Aldrich (Milwaukee, WI). The
guanidine hydrochloride (GdHCl) (Sequanol grade) was from Pierce
(Rockford, IL). The Sephadex G-25 fine powder was supplied by Phar-
macia Biotech (Uppsala, Sweden). All water was distilled twice and
deionized to a specific resistivity of at least 18 Mcm with a Milli-Q 5
stage water purification system. All other chemicals were of analytical
grade and were used without further purification.
Protein labeling and purification
A small amount of protein (1 mg) was dissolved into 1 ml of 10 mM
phosphate buffer containing 100 mM KCl at pH 7.2. This was then passed
through a Sephadex G-25 column (height 10–20 cm, diameter 1 cm) with
10 mM phosphate buffer to elute the protein. The purified protein was
labeled as described previously (Wang et al., 1996). Briefly, acrylodan and
HSA were mixed in a 2:1 molar ratio and allowed to stir in the dark for 24 h
at room temperature. Unlabelled acrylodan was dialyzed against 10 mM
phosphate buffer over a 4-day period, with an exchange of buffer every
12 h. The labeled protein was then passed through a G-25 sephadex column
to dislodge any unreacted label. The concentration of labeled protein was
found by using 278  8,700 M
1 cm1 and 365  12,800 M
1 cm1 for
acrylodan (Edmiston et al., 1994) and 277  36,000 M
1 cm1 for HSA
(Pico, 1997). The labeling efficiency was determined to be 80%.
Steady-state fluorescence measurements
Fluorescence excitation and emission spectra were collected from labeled
and unlabeled HSA with instrumentation that has been described previ-
ously (Zheng et al., 1997). Samples containing unlabeled HSA were
excited at 295 nm, and emission was collected from 305 nm to 450 nm in
1-nm increments with an integration time of 0.50 s, using 4 nm bandpasses
in both the excitation and emission paths. Acrylodan-labeled HSA was
excited at 360 nm, with emission collected from 400 nm to 600 nm to
examine the acrylodan residue alone. For energy transfer experiments, the
labeled protein was excited at 295 nm, and emission was collected from
305 nm to 600 nm. Excitation spectra of acrylodan were collected from 315
nm to 470 nm with emission at 500 nm.
Steady-state fluorescence anisotropy measurements were done as de-
scribed elsewhere (Wang and Bright, 1993), with excitation at 295 nm and
emission at 340 nm for studies of Trp, 360 nm excitation and 500 nm
emission to measure the anisotropy of acrylodan, or 295 nm excitation and
500 nm emission to measure the effects of energy transfer on anisotropy.
All experiments were done with 30 M protein to provide a sufficient
signal with the polarizers in place. Steady-state anisotropy values (r) were
used to obtain average rotational correlation times (), using the mean
fluorescence lifetime () and limiting anisotropy (r0), as follows:
r
r0
1 /
(1)
Time-resolved fluorescence measurements
Time-resolved fluorescence measurements of Trp were performed by the
time-correlated single photon counting method (O’Connor and Phillips,
1984). The excitation source was a cavity dumped dye laser synchronously
pumped by an actively mode-locked argon ion laser (Spectra Physics)
operating at 825 kHz with a pulse width of 15 ps. Emission, following
vertically polarized excitation at 295 nm, was detected (right angle geom-
etry) after passing through a polarizer set at 55° to the vertical and a JY
H10 monochromator with a 4-nm bandpass, using a Hamamatsu 1564U-01
microchannel plate photomultiplier tube. The channel width was 10 ps/
channel, and data were collected in 1024 channels. The instrument re-
sponse function was determined from the Raman scattering of water and
typically had a FWHM of 	70 ps. Counts from a blank were measured for
each sample for the same accumulation time, and the blank counts were
subtracted from the sample decay curve.
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Time-resolved intensity and anisotropy decay data for the acrylodan
label were acquired in the frequency domain with a SLM 48000 MHF
multifrequency phase-modulation fluorometer. An argon ion laser (Coher-
ent, model Innova 90-6) operating at 351.1 nm was used as the excitation
source. A bandpass filter was placed in the excitation path to minimize
extraneous plasma discharge in the detection system. Magic angle polar-
ization was used for all excited-state intensity decay experiments.
Me2POPOP in ethanol served as the reference lifetime standard; its lifetime
was assigned a value of 1.45 ns. For all experiments, the Pockel cell was
operated at a repetition rate of 5 MHz. Typically, data were collected for
60–90 s over a frequency range of 5–250 MHz. All multifrequency phase
and modulation data were analyzed according to a global analysis method
described elsewhere (Wang and Bright, 1993).
For both time-domain and frequency-domain measurements of intensity
decays, the function describing the fluorescence intensity decay was as-
sumed to be a sum of exponential components:
I, t 
i
	iexpt/i (2)
where i is the decay time of the ith component and 	i() is the preexpo-
nential factor at emission wavelength . The fractional fluorescence of
component i at wavelength  (fi()) was calculated from
fi 	ii
i
	ii (3)
From this, the mean lifetime values are obtained from the following
equation:

 
i
fii (4)
Time-resolved decays of fluorescence anisotropy (r(t)) were fit to a
double exponential decay of the form
rt r0
1 expt/1 
2 expt/2 (5)
where 1 depends solely on the local rotational reorientation of the probe
and 2 depends on the global motions of the entire biomolecule. The terms

1 and 
2 represent the fractional contributions to the total anisotropy
decay from the local and global motions, respectively (
i  1). In the
situation where the local probe motion is faster than the global motion of
the entire protein, the local rotational motion of the probe L is given as
1/(1/2  1/1).
A semiangle () can be associated with the cone within which the probe
is able to precess during its excited-state fluorescence lifetime, given by
  cos10.58
11/2 11/2 1 (6)
If the environment surrounding the probe is totally restrictive to the local
probe motion,  will approach 0°. In contrast, complete freedom of the
probe to rotationally reorient will result in a  value of 90°. Intermediate 
values reflect partial freedom of the probe to reorient within its cybotactic
region.
Energy transfer measurements
The efficiency of energy transfer (E) as a function of distance (R) between
two probes was determined from fluorescence lifetime values as follows
(Campbell and Dwek, 1984):
E 1DAD  1 DAD  R0
6
R6 R06
(7)
where R0 represents the distance at which energy transfer is 50% efficient,
DA and DA are the quantum yield and fluorescence lifetime of the donor
in the presence of the acceptor, respectively, and D and D are the
unquenched donor quantum yield and lifetime in the absence of acceptor,
respectively. The value of R0 (in nanometers) was obtained from Eq. 8
(Campbell and Dwek, 1984):
R0 9.79 102Jn42D1/6 (8)
where J is the overlap integral, n is the solution refractive index, and 2 is
the orientation factor between the donor and acceptor electronic transition
dipole moments. The overlap integral was determined by using the overlap
of the acrylodan excitation spectrum and the Trp emission spectrum,
according to standard methods (Campbell and Dwek, 1984).
Chemical denaturation studies
Chemical denaturation studies were carried out with 1.50 ml of 0.5 M
HSA or 1.0 M HSA-Ac solution. Samples were titrated with 8.0 M
GdHCl with constant stirring, and a minimum of 10 min was allowed for
equilibration (with a shutter blocking the excitation light). A fluorescence
spectrum or a steady-state anisotropy value was collected at each point for
both the sample and a blank containing an identical concentration of
GdHCl. The spectra were corrected for contributions from the blank and
instrument factors as well as for dilution factors. Unfolding curves were
obtained by integrating and normalizing the spectra and were fit by using
Eq. 9 (Santoro and Bolen, 1988):
FD
FN mND FU mUD
expGF3U/RT mGD/RT
1 expGF3U/RT mGD/RT
(9)
where FD is the value of the fluorescence intensity (or anisotropy) at a
given concentration of denaturant, [D], R is the gas constant, and T is the
temperature. The remaining six terms are fitting parameters, where FN and
FU are the values of the intensity or anisotropy extrapolated to zero
denaturant concentration for the native and unfolded states, respectively;
mN and mU are the slopes for the dependencies of FN and FU on denaturant
concentration; G(F3U) is the free energy of unfolding; and mG is the slope
describing the dependence of G(F3U) on denaturant concentration. The
transition midpoint (D1/2) values can be calculated by dividing G(F3U) by
mG.
Thermal denaturation studies
A volume of 1.5 ml of 1.0 M HSA or HSA-Ac was placed in a quartz
fluorimeter cuvette. The temperature was raised in 	3°C increments,
starting at 20°C and going to 70°C or 80°C. A fluorescence spectrum or
anisotropy value was collected from the sample and from an appropriate
blank at each temperature. The temperature of the solution in the cuvette
was measured directly with a thermistor probe (Hanna Instruments model
9043A) to account for loss of heat through the Tygon tubing connecting the
sample holder and the water bath. The samples were allowed to equilibrate
for at least 5 min at each temperature before readings were taken with a
shutter blocking the excitation beam. The spectra were integrated over a
40-nm window centered about the emission maximum. The resulting
unfolding curve was analyzed by nonlinear fitting to the equation described
by Eftink (1994):
FT
F0N sNT F0U sUTexpHun0  TSun0 /RT
1 expHun0  TSun0 /RT
(10)
where FT is the measured intensity (or anisotropy) at some temperature T,
and R is the gas constant. The remaining six terms are fitting parameters,
where F0N and F0U are the fluorescence intensity (or anisotropy) of the
native and unfolded states, respectively; sN and sU are the baseline slopes
of the native and unfolded states as a function of temperature, respectively;
and H°un and S°un are the enthalpy change and entropy change for the
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unfolding reaction, respectively. The free energy change for unfolding
(Gun) is then determined by
GunTr Hun0  TrSun0
 Cp,unTr Tun Tun lnTr/Tun
(11)
where Tr is a reference temperature (usually 20°C), Tun is the temperature
of unfolding (given by H°un/S°un), and Cp,un is the differential heat
capacity for unfolding, which accounts for the temperature sensitivity of
the entropy and enthalpy terms on going from Tr to Tun.
Salicylate titrations of HSA
A solution of 5 M HSA in 10 mM phosphate buffer was titrated with 50
M salicylate in 10 mM phosphate buffer at pH 7.2. Spectra were collected
for salicylate in both the presence and absence of HSA. A 40-nm window
centered about the emission wavelength maximum at 408 nm was inte-
grated to provide intensity values for the ligand at each salicylate concen-
tration, and this value was corrected for dilution factors and for the
fluorescence of the blank. Linear regression was performed on the ligand
binding curve to quantitate the relative binding affinity of the HSA (Brown
and Crooks, 1976). This experiment was performed on native, thermally
denatured, and chemically denatured protein samples.
Acrylamide quenching studies
Acrylamide was used to quench the Trp residue in unlabeled HSA. A
volume of 2.0 ml of a 0.5 M HSA solution was titrated with 8.0 M
acrylamide in buffer. A fluorescence spectrum was collected from the
sample and an appropriate blank after each addition with excitation at 295
nm and emission from 305 nm to 450 nm. Spectra were corrected for
sample dilution and were integrated from 310 nm to 450 nm. The quench-
ing data were fit using a modified version of the Stern-Volmer equation,
which accounted for both dynamic and static contributions to the quench-
ing process:
F0
FeVQ 1 KSVQ 1 kq0Q (12)
where F0 is the fluorescence intensity in the absence of quencher, F is the
fluorescence in the presence of quencher, [Q] is the molar concentration of
the quencher, KSV is the Stern-Volmer quenching constant for the colli-
sional process (M1), kq is the bimolecular quenching constant
(M1  s1), 0 is the unquenched excited state fluorescence lifetime, and
V is the active volume of the sphere surrounding the fluorophore, within
which no diffusion is necessary to initiate quenching (Eftink and Ghiron,
1976).
O2 quenching of HSA-Ac
The oxygen quenching of the acrylodan residue of HSA-Ac was carried out
with a stainless steel high-pressure O2 cell similar to the one described by
Lakowicz et al. (Lakowicz and Weber, 1973) (Note: These experiments
require the use of moderately high pressures. One must exercise extreme
caution when working with high-pressure gases, especially O2.) A temper-
ature-regulated fluid was pumped directly through a coil within the cell to
ensure temperature control (20  1°C). O2 from a standard gas cylinder
was introduced directly into the cell through stainless steel tubing and a
valve. The internal cell pressure was monitored (1 psia) with a standard
digital pressure transducer. The solution was constantly stirred throughout
the experiment, and all samples were allowed to equilibrate until the
fluorescence was constant (Ingersoll et al., 1996). The concentration of
HSA-Ac within the cell was 2.0 M. Data were analyzed according to a
protocol outlined elsewhere (Ingersoll et al., 1996).
RESULTS AND DISCUSSION
Chemical denaturation
The unfolding behavior of HSA and HSA-Ac was first
examined by chemical denaturation with GdHCl. The
changes in the steady-state and time-resolved fluorescence
intensity and anisotropy were monitored for both the Trp in
HSA and HSA-Ac and for the acrylodan moiety of HSA-
Ac. The Trp residue within the native, unlabeled protein had
an emission maximum of 335 nm, a quantum yield of
0.14  0.01, and a steady-state anisotropy value of 0.180
0.002. From Eq. 1, this indicates that the average rotational
correlation time for native HSA is 4.15  0.04 ns. These
values are consistent with the Trp residue being located in
an environment of intermediate polarity with an intermedi-
ate degree of motion (i.e., some local motion that reduces r).
Denaturation of HSA using GdHCl was monitored by
changes in integrated fluorescence intensity and steady-state
anisotropy, as shown in Figs. 1 A and 2. Initially, there was
a preunfolding baseline with no major changes in intensity
or anisotropy. However, there was a slight blue shift in the
emission wavelength of the Trp residue (to a value of 330
nm) before the first stage of unfolding (spectra not shown).
The intensity data, shown in Fig. 1 A, indicated that the
protein denatured by a two-stage process. The first unfold-
ing transition occurred between 1.0 M and 2.2 M with a
large change in intensity (50%). This transition was accom-
panied by a red shift in the wavelength from 330 nm to 345
nm. The intensity data also indicated that there was a second
unfolding transition between 2.2 M and 3.0 M, with a much
smaller change in intensity (	20%), and no further wave-
length shift. Anisotropy changes, shown in Fig. 2 (lower
curve), showed one distinct unfolding step at a denaturant
level similar to that observed for intensity measurements,
and a drawn-out baseline, which is presumably due to the
second unfolding step. The final anisotropy value was
0.070  0.002 at 4.0 M GdHCl, corresponding to an aver-
age rotational correlation time of 0.58  0.02 ns. The
decrease in anisotropy is indicative of a substantial increase
in the mobility of the Trp residue, and is consistent with
unfolding of the protein. The transition reported by steady-
state fluorescence anisotropy measurements was broader
than that reported by intensity measurements, consistent
with the differential quantum yield weighting of the folded
and unfolded forms of the protein (Eftink, 1994).
Acrylamide quenching of the Trp residue at different
levels of GdHCl indicated that the value of kq increased
from 0.6  109 to 1.1  109 M1 s1 on going from 0.0 M
to 2.0 M GdHCl. The results are consistent with the unfold-
ing of domain II causing increased exposure of the Trp
residue, and correspond to the range for the major emission
wavelength shift. Beyond 2.0 M the kq value remained
constant at 1.0  109 M1 s1, indicating that the second
unfolding step did not cause changes in the exposure of the
Trp residue. From this data, it appears that the unfolding of
domain II occurs over the denaturant range between 1.0 and
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2.0 M, and a second unfolding step not directly involving
domain II occurs at denaturant levels above 2.0 M.
Analysis of the unfolding curve (Fig. 1 A) by Eq. 9
provided G(F3U) values of 30.0  1.3 kJ  mol1 for the
first stage of unfolding and 35.0  1.5 kJ  mol1 for the
second stage of unfolding, as shown in Table 1. Thus the
total change in free energy for unfolding of HSA was
65.0  4.8 kJ  mol1. Farruggia et al. (1997) obtained a
value of 23 kJ  mol1 with a D1/2 of 2.75 M for unfolding
of HSA, but did not witness a two-stage unfolding process.
Our initial experimental results indicated a one-step unfold-
ing with a G(F3U) value of 25.9  2.2 kJ  mol1, but
these results were obtained under conditions where samples
were not given sufficient time to reach equilibrium after the
addition of GdHCl. Only when sufficiently long equilibra-
tion times were used (10 min per aliquot of denaturant) was
the unfolding of HSA observed to be a multistep process.
Removal of GdHCl by dialysis resulted in a recovery of
the shape of the spectral contour for Trp, along with recov-
ery in terms of emission wavelength, anisotropy, and
quencher accessibility. However, the intensity did not re-
cover to the initial value before unfolding, suggesting that
the native structure may not have been fully recovered. To
further examine the changes in protein structure and func-
tion on denaturation and recovery, we determined the bind-
ing of salicylate to HSA at different denaturant levels and
for protein that had the GdHCl removed by dialysis. HSA
containing even low levels of GdHCl (less than 1.0 M) was
unable to bind salicylate. However, at such levels the re-
moval of the denaturant by dialysis restored the binding
capability of the protein, indicating that the initial confor-
mational changes reported by the blue shift in the Trp
emission wavelength were reversible. Denaturation and re-
covery of HSA, using GdHCl at levels of 2.0 M or higher,
where domain II was fully unfolded, resulted in a large
decrease in the ability of the protein to bind salicylate,
showing that domain II unfolding was not fully reversible.
Thus, even though the spectral and quenching data suggest
a similar environment for the Trp residue for native and
refolded HSA, the binding studies clearly show that unfold-
ing of domain II causes irreversible changes in the structure
and function of the protein.
FIGURE 1 Changes in integrated intensity during chemical denaturation
of HSA and HSA-Ac using GdHCl. (A) Trp emission from HSA excited at
295 nm. (B) Trp emission from HSA-Ac excited at 295 nm. (C) Acrylodan
emission from HSA-Ac excited at 360 nm.
FIGURE 2 Steady-state anisotropy of HSA and HSA-Ac during chem-
ical denaturation. f, Anisotropy of Trp from HSA with excitation at 295
nm. F, Anisotropy of acrylodan within HSA-Ac with excitation at 360 nm.
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To examine the unfolding behavior of domain I, denatur-
ation of HSA-Ac was carried out. Incorporation of the
acrylodan label resulted in dramatic changes in the intensity
of the Trp signal for both the native and the unfolded
protein, although the spectral contours corresponding to
these forms (i.e., emission maximum and full width at
half-maximum) were identical to those obtained for the
unlabeled protein (spectra not shown). The measured quan-
tum yield of the native protein dropped from 0.14  0.01 to
0.03  0.01, indicating that acrylodan was able to quench
the Trp fluorescence. These results strongly suggest that the
acrylodan label influenced the Trp signal, owing to a reso-
nance energy transfer effect, with the Trp residue acting as
the donor and the acrylodan label acting as the acceptor.
This effect is described in more detail below.
Chemical denaturation of HSA-Ac resulted in a signifi-
cantly different unfolding curve when the Trp emission was
monitored, as shown in Fig. 1 B. The unfolding curve for the
protein was altered such that the intensity of the Trp signal
increased significantly (15%) between 0.0 M and 1.0 M
denaturant. This range is similar to that for the blue shift in
the Trp emission wavelength maximum, and is consistent
with a separation of domain I and domain II such that the
quenching of the Trp residue is partially relieved. The main
unfolding transition occurred between 1.0 M and 2.0 M of
GdHCl, and had a D1/2 value of 2.0 M, which was similar to
that obtained for the unfolding of unlabeled HSA. Beyond
2.0 M the intensity of the Trp emission increased in a fairly
linear fashion, suggesting that the unfolding of domain I
containing the acrylodan label was affecting the Trp signal
from domain II, in agreement with the behavior observed
for unlabeled HSA (Fig. 1 A). It is interesting to note that
the second unfolding step is not observable, unlike the case
of unlabeled HSA. This is likely due to a broad distribution
of Trp-acrylodan donor-acceptor distances within the par-
tially denatured HSA-Ac, causing a broadening of the un-
folding transition.
Unfolding curves were also obtained for HSA-Ac when
the acrylodan label was excited directly at 360 nm and the
acrylodan emission was observed during denaturation. Fig.
1 C shows the changes in integrated intensity during dena-
turation, and Fig. 2 (upper curve) shows the changes in
steady-state anisotropy. O2 quenching of the acrylodan label
was also carried out at various denaturant levels. In this
case, the intensity of the acrylodan label increased by	15%
during the addition of the first 2.0 M of denaturant, reaching
a maximum between 1.5 and 2.0 M GdHCl, although the
anisotropy and kq value remained relatively constant over
this range. This range correlates to that for the initial domain
separation and unfolding of domain II, as shown by the Trp
fluorescence of HSA and HSA-Ac, and indicates that these
processes result in a change in the local conformation of
domain I in the region surrounding Cys34. The main unfold-
ing transition reported by the acrylodan intensity changes
occurred over a fairly broad range between 2.0 M and 4.0 M
GdHCl, with a D1/2 value of 2.7 M. The kq value also
increased by nearly twofold over this range, indicating that
the acrylodan moiety became more solvent exposed. Be-
yond 4.0 M GdHCl, the intensity and kq value remained
relatively constant, indicating that full unfolding of the
structure occurred upon the addition of	4.0 M GdHCl. The
corresponding anisotropy decrease for the acrylodan label
occurs in two stages, with a small anisotropy change be-
tween 1.0 M and 2.2 M denaturant, and a larger change
between 4.0 and 5.0 M GdHCl. The initial change is con-
sistent with an overall increase in the global motion of the
protein upon unfolding of domain II. The second step is
consistent with the unfolding of domain I. The steady-state
anisotropy changes again lag behind the integrated intensity
changes, as observed for Trp, owing to the differential
quantum yield weighting of the native and unfolded states
(Eftink, 1994). Overall, the results from the acrylodan emis-
sion clearly show that the unfolding of domain I occurs only
after domain II has fully unfolded, and supports the pres-
ence of a multistep unfolding process, as suggested by
changes in the Trp fluorescence of HSA.
The multistep unfolding profile reported by the intensity
and anisotropy data provides evidence that the protein un-
folding pathway involves at least one intermediate. This is
contrary to the findings of Tayyab et al. (1995), who exam-
ined urea-induced denaturation of HSA with fluorescence
measurements and found that unfolding apparently occurred
in a single, concerted step. However, studies by Wallevick
(1973) suggested that the unfolding of HSA with GdHCl is
TABLE 1 Thermodynamic parameters for GdHCl-induced unfolding of HSA
Sample
G(F3U) (kJ 
mol1)* mG (kJ  L  mol2)* D1/2 (M)# 2§
Trp in HSA (Stage 1)¶ 30.0  1.8 20.1  1.1 1.5  0.2 0.97
Stage 2 35.0  1.5 13.0  0.9 2.7  0.2 0.97
Trp in HSA-Ac** 29.7 5.0 15.0  2.4 2.0  0.2 0.98
Acrylodan in HSA-Ac## 14.7  1.1 5.7  0.5 2.6  0.3 0.99
*These values were obtained by fitting of unfolding curves to Eq. 3.
#This value was obtained by dividing Gun by mG.
§Determined from nonlinear curve fitting, using SigmaPlot 1.02 for Windows.
¶Fitting parameters: FN  0.999, FU  1.104, mN  0.033, mU  0.245.
Fitting parameters: FN  1.044, FU  0.332, mN  0.245, mU  0.011.
**Fitting parameters: FN  0.942, FU  0.632, mN  0.050, mU  0.016.
##Fitting parameters: FN  0.862, FU  0.832, mN  0.093, mU  0.046.
Flora and Brennan Fluorescence Study of Acrylodan-Labeled HSA 1089
a multistep process at physiological pH values, in agreement
with our findings. Chmelik et al. (Chmelik and Kalous,
1982) have also reported finding, by polarography, a two-
step unfolding of HSA by urea.
Time-resolved intensity data for the Trp residue within
HSA and for the Trp and acrylodan within HSA-Ac were
obtained for proteins in the presence of 0 M, 1.0 M, 2.0 M,
and 4.0 M GdHCl, as shown in Table 2. The mean lifetime
value for Trp in native HSA was 5.28  0.03 ns, which is
in reasonable agreement with the value of 5.60 ns reported
elsewhere (Helms et al., 1997). Comparison of Trp lifetime
values for HSA and HSA-Ac allowed for an examination,
using Eq. 7, of interdomain distance relationships at differ-
ent denaturant levels. The value of R0 for the native protein
was first calculated (and was determined to be 2.70  0.03
nm) using a donor quantum yield of 0.14, a J value of
(8.91  0.09)  1015 cm3 M1, and with 2 set to 2/3 and
n set to 1.50. Based on the differences in the intensity-
weighted mean lifetime of native HSA and HSA-Ac, the
energy transfer efficiency of the folded protein was deter-
mined to be 28.3  0.2%, corresponding to an interdomain
distance of 3.15  0.03 nm. This value is in excellent
agreement with the value of 3.18 nm reported by Hagag et
al. (1983). At 1.0 M, the mean lifetime values of the Trp
residue in HSA and HSA-Ac both dropped slightly, indi-
cating a slight decrease in energy transfer efficiency to
25.0  0.2%. This indicates that the interdomain distance
had increased to 3.26  0.03 nm, suggesting that interdo-
main separation likely occurred before domain unfolding
took place. This interpretation is in agreement with the
increase in Trp emission intensity observed during the ini-
tial stages of denaturation for HSA-Ac (Fig. 1 B).
At 2.0 M GdHCl, the mean lifetime value of Trp in both
proteins dropped significantly, indicating a large change in
the environment of the Trp residue. Comparison of the
lifetime values for the two proteins indicated that the energy
transfer efficiency increased to 36.7  0.4%, corresponding
to a decrease in the Trp-acrylodan distance to 2.96  0.03
nm. This decrease in the donor-acceptor distance occurs at
a point where domain II is unfolded but domain I is intact.
Thus, under these conditions, the Trp residue is apparently
free to move closer to the acrylodan moiety, producing a
slight decrease in the average Trp-acrylodan distance. The
overall structural change in the protein may explain the
observed increase in the directly excited acrylodan emission
intensity between 0.0 and 2.0 M GdHCl, shown in Fig. 2 C.
At 4.0 M GdHCl, the mean lifetime values of the Trp
within HSA and HSA-Ac show a further decrease, and the
fractional contribution of each decay component shifts to
emphasize the two longer decay components. The energy
transfer efficiency drops to 13.2  0.1%, corresponding to
an average Trp-acrylodan distance of 3.69 0.05 nm. Thus,
after domain I unfolds, the protein adopts an extended
conformation, with the distance between the Trp and acry-
lodan moieties increasing substantially. The relative close-
ness of the two probes for the unfolded protein may be
explained by the fact that the disulfides were not reduced;
thus complete unfolding does not occur.
TABLE 2 Fluorescence intensity decay parameters for the Trp residue within HSA and HSA-Ac as a function of denaturant
concentration
Sample 	1 	2 	3 f1* f2 f3
1
(ns) 2 (ns) 3 (ns)


(ns)# 2
Tryptophan in HSA
0 M GdHCl 0.57 0.29 0.14 0.79 0.20 0.01 5.913 3.046 0.231 5.28 1.054
1 M GdHCl 0.59 0.24 0.17 0.85 0.14 0.01 5.453 2.135 0.080 4.98 1.103
2 M GdHCl 0.38 0.37 0.25 0.73 0.25 0.02 5.114 1.857 0.214 4.19 1.062
4 M GdHCl 0.48 0.41 0.11 0.70 0.28 0.02 3.230 1.516 0.310 2.73 1.004
0 M GdHCl
(recovered)
0.40 0.35 0.25 0.73 0.25 0.02 5.951 2.251 0.257 4.92 1.089
Tryptophan in HSA-
Ac
0 M GdHCl 0.36 0.27 0.37 0.79 0.19 0.02 4.473 1.420 0.143 3.79 1.070
1 M GdHCl 0.31 0.29 0.40 0.77 0.21 0.02 4.439 1.325 0.074 3.70 1.010
2 M GdHCl 0.30 0.35 0.25 0.73 0.24 0.03 3.314 0.930 0.152 2.65 1.011
4 M GdHCl 0.22 0.35 0.42 0.61 0.34 0.05 3.229 1.118 0.147 2.36 1.020
Acrylodan in HSA-Ac
0 M GdHCl 0.60 0.40 — 0.77 0.23 — 4.330 1.886 — 3.775 1.005
0.5 M GdHCl 0.61 0.39 — 0.80 0.20 — 4.212 1.656 — 3.698 1.017
1 M GdHCl 0.65 0.35 — 0.85 0.15 — 4.002 1.325 — 3.606 1.021
2 M GdHCl 0.65 0.35 — 0.84 0.16 — 3.972 1.377 — 3.562 1.009
4 M GdHCl 0.62 0.38 — 0.83 0.17 — 3.779 1.282 — 3.365 1.029
5 M GdHCl 0.61 0.39 — 0.81 0.19 — 3.610 1.312 — 3.166 1.045
6 M GdHCl 0.48 0.52 — 0.71 0.29 — 3.470 1.320 — 2.853 1.121
*Calculated from Eq. 3.
#Calculated from Eq. 4.
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Refolding the protein by dialysis of the GdHCl resulted in
the lifetime recovering to a value of 4.92  0.04 ns. How-
ever, the fractional contribution of each decay component
was different from those observed for the native protein.
The results clearly indicated that the native structure was
not recovered upon protein refolding, at least in the region
of the Trp residue. The decay of Trp fluorescence intensity
for refolded HSA-Ac could not be reliably fit, and therefore
it was not possible to obtain Trp-acrylodan distance infor-
mation in this case.
Time-resolved intensity measurements were also made of
acrylodan within HSA-Ac, as a function of GdHCl concen-
tration. The results are shown in Table 2. Both the long and
short lifetime components decrease as the GdHCl concen-
tration increases, as expected based on the unfolding model
proposed above for HSA. The initial changes seen between
0.5 and 1.0 M GdHCl are consistent with changes in the
local environment of the probe, whereas changes of the
global protein structure are observed between 1.0 and 6.0 M
GdHCl. These results support the suggestion that the major
changes in the environment of the acrylodan label occur at
higher levels of denaturant, which is consistent with the
unfolding of domain I containing the acrylodan label at high
denaturant levels.
Time-resolved fluorescence anisotropy decays of the ac-
rylodan moiety in HSA-Ac were also measured. These
results are summarized in Fig. 3. The results show that the
initial global reorientation time is quite large (	80 ns),
suggesting that multimers of the protein may have been
present. A small decrease in the global rotational reorienta-
tion time occurs between 1.0 M and 3.0 M, suggesting that
the global motion of the entire protein increases over this
range of denaturant. There is also a small increase in the
fractional contribution of the shorter rotational correlation
time, suggesting greater acrylodan residue freedom. Be-
tween 3.0 M and 6.0 M GdHCl, the two rotational correla-
tion times remain essentially constant; however, the contri-
bution from the shorter component and the semiangle of
rotation for the acrylodan label increase significantly. This
is consistent with an opening of the pocket hosting the
acrylodan reporter group, such that a higher proportion of
acrylodan labels are able to freely rotate, and reflects the
unfolding of domain 1 beyond 2.0 M GdHCl.
Thermal denaturation
Thermal denaturation experiments were also performed and
were used to validate the multi-step unfolding model. Figs.
4 and 5 present the changes in integrated intensity and
steady-state anisotropy as a function of temperature for
HSA, HSA-Ac excited at 295 nm (Trp emission, not shown
in Fig. 5), and HSA-Ac excited at 360 nm (acrylodan
emission). Unfolding of HSA (circles in Fig. 4) appeared to
occur as a single step, contrary to the results obtained for
chemical denaturation of HSA as monitored by Trp inten-
sity. The Trp intensity decreased by 60%, with the emission
wavelength maximum blue shifting and the anisotropy de-
creasing from 0.180  0.003 to 0.118  0.002 during the
unfolding transition. The latter anisotropy value corre-
sponds to an average rotational correlation time of 1.25 
FIGURE 3 Time-resolved decay of acrylodan anisotropy during chem-
ical denaturation of HSA-Ac. (A) Fluorescence rotational correlation times
for global (2) and local (1) rotational components. (B) Fractional con-
tribution of 1 as a function of denaturant concentration. (C) Semiangle of
probe rotation obtained during chemical denaturation of the protein. The
error bars on each panel denote 1 standard deviation from at least three
discrete measurements.
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0.02 ns, which is double that obtained during chemical
denaturation. Furthermore, above 60°C, the anisotropy of
the Trp residue increased. Taken together, these results
provide evidence that protein aggregates on thermal unfold-
ing, and thus does not end up in the same final state as
obtained from chemical denaturation. This is consistent
with the observation that thermally denatured HSA aggre-
gates (Pico, 1995; Wetzel et al., 1980), whereas chemically
denatured HSA does not. As the protein was cooled to 20°C,
the anisotropy of the Trp residue returned to the initial value
of 0.180  0.002. However, the mean fluorescence lifetime
(from Table 3) did not return to the value obtained for the
native protein, resulting in a mean rotational correlation
time of 3.71  0.07 ns. Hence the mobility of the Trp
residue was greater in the refolded state as compared to the
native state. This clearly indicated that the protein did not
refold to its original form after a single heating and cooling
cycle.
Monitoring of Trp emission from HSA-Ac (squares in
Fig. 4) provided evidence of two unfolding steps, in quali-
tative agreement with the multistep unfolding observed
during chemical denaturation. In addition, the intensity of
the Trp signal of HSA-Ac initially increased upon unfold-
ing, consistent with an initial increase in the donor-acceptor
distance with increasing temperature. With the exception of
the two-step unfolding profile, the changes in Trp emission
characteristics (intensity, wavelength, anisotropy) during
unfolding were similar to those for unlabeled HSA.
Monitoring of acrylodan fluorescence (triangles in Fig.
4) also showed an initial increase in acrylodan intensity
between 20°C and 30°C. Given that energy transfer is not
possible under these experimental conditions, the spectro-
scopic changes provide evidence of a global change in
protein structure that affected the environment in the region
of both the Trp and the acrylodan label. Hence the initial
structural changes involving domain separation must also
have a direct effect on the environment surrounding Trp214
and Cys34. Salicylate binding studies done at 40°C showed
retention of partial binding function; hence complete do-
main separation was not evident at this point. Recovery of
the temperature to 20°C resulted in almost full recovery of
salicylate binding, suggesting that the initial changes in
structure were reversible, in agreement with the chemical
denaturation studies.
Between 30°C and 60°C, the acrylodan intensity varies
somewhat, whereas the emission maximum blue shifts from
495 nm to 490 nm. The steady-state fluorescence anisotropy
of the acrylodan label (Fig. 5, circles) also showed a sig-
nificant decrease, corresponding reasonably well to the pre-
transition region (30–50°C). This clearly shows that the
unfolding of domain II has a major effect on the environ-
ment of the acrylodan probe in domain I. Between 60°C and
90°C, the intensity and anisotropy of the acrylodan label
decreased substantially, indicating the main unfolding tran-
sition of domain I. Over this range, the emission maximum
of the acrylodan label blue shifted to 480 nm, indicating a
decrease in the polarity in the local region of Cys34. It is
interesting to note that the emission maximum of the acry-
lodan label red shifted during chemically induced unfold-
ing, which is opposite the trend observed during thermal
denaturation. This suggests that domain I was able to fully
unfold upon exposure to GdHCl, but could not unfold at
high temperature. This is further supported by the final
anisotropy value of 0.180 at 90°C, which is substantially
higher that that for acrylodan in solution (racrylodan 0.005),
indicating that the protein was not fully unfolded at this
temperature. The data are consistent with aggregation of the
protein at higher temperatures. Salicylate binding studies of
protein that was recovered from heating at 80°C indicated a
FIGURE 5 Steady-state fluorescence anisotropy of HSA and HSA-Ac
during thermal denaturation. f, Anisotropy of Trp from HSA with exci-
tation at 295 nm. F, Anisotropy of acrylodan within HSA-Ac with exci-
tation at 360 nm.
FIGURE 4 Changes in integrated intensity and emission wavelength of
HSA and HSA-Ac monitored as a function of temperature. F, Trp emission
of HSA. f, Trp emission from HSA-Ac. Œ, Acrylodan emission from
HSA-Ac.
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large loss of binding function, confirming that the recovered
protein was only partially functional.
The thermal melting curves derived from measurements
of Trp intensity in HSA and HSA-Ac were examined using
Eq. 10. The thermodynamic parameters for HSA indicated
an enthalpy of unfolding of 350  23 kJ  mol1, an en-
tropy of unfolding of 1050  71 J  K1  mol1, and a Tun
value of 60  4°C (note: other fitting parameters were as
follows: F0N  1.251, F0U  0.850, sN  0.009, sU 
0.006). These values are in excellent agreement with
literature values (Pico, 1995, 1996, 1997). The Gun value
was determined to be 42 kJ  mol1 if the Cp,un value was
set to zero. Use of the Cp,un values provided by Pico
(1997) resulted in negative free energy values at a reference
temperature of 20°C, suggesting that these values may be
erroneous. Thus all Gun values reported herein use a
Cp,un value of zero. Thermodynamic analysis of the first
unfolding step for HSA-Ac yielded thermophysical values
that were similar to those obtained for unlabeled, native
HSA (Hun  380  25 kJ  mol1, Sun  1160  60
J  K1 mol1, Gun  39.6  6.7 kJ  mol1, F0N 
1.142, F0U  1.012, sN  0.006, sU  0.007). From
these values, the unfolding temperature was calculated to be
55  3°C, which is in reasonable agreement with the value
obtained for unlabeled, native HSA. The small differences
in the Tun values likely reflect the influence of the acrylodan
label on the emission properties of Trp within HSA-Ac,
because of energy transfer. Circular dichroism spectra of
HSA-Ac obtained in 10 mM phosphate buffer containing
100 mM KCl, pH 7.2, suggested that the labeled protein was
64% 	-helix, 21% 
-sheet, and 15% random coil (data not
shown). These values are in excellent agreement with those
obtained by Wetzel et al. (1980) for native HSA under
similar conditions (61% 	-helix, 22% 
-sheet, 17% random
coil). These results indicate that labeling of Cys34 had no
significant effect on the conformation of the native protein,
ruling out such changes as the basis of the lower Tun for
HSA-Ac.
The unfolding curve derived from measurements of ac-
rylodan fluorescence intensity could not be fit to Eq. 10,
because there was no postunfolding region, owing to the
inability of our instrument to heat samples beyond 92°C.
However, qualitative analysis of the unfolding curve sug-
gests that the Tun is at least 75°C. It must be noted that the
determination of thermodynamic parameters relies on the
protein unfolding being reversible. The spectroscopic pa-
rameters strongly suggest that this is not a valid assumption
for HSA; thus the thermodynamic data presented above
should be treated with caution.
The time-resolved decay of fluorescence intensity was
examined for the Trp residue of HSA and the acrylodan
probe of HSA-Ac at different temperatures and upon recov-
ery from 75°C (for HSA) or 80°C (for HSA-Ac). The results
are given in Table 3. Unfolding of the protein by raising the
temperature to 75°C resulted in the decay being best fit by
two decay components and caused a decrease in the inten-
sity-weighted mean fluorescence lifetime from 5.28  0.03
ns to a value of 2.50  0.05 ns. Refolding the protein by
decreasing the temperature to 20°C resulted in the reappear-
ance of the third decay component; however, the lifetime
recovered to only 4.72  0.09 ns. In addition, the fractional
contributions of each decay component were different from
those observed for the native protein, with the fraction of the
shortest component increasing at the expense of the longest
component. This clearly indicated that the native protein
structure was not fully recovered upon protein refolding, at
least in the region of the Trp residue, in agreement with the
chemical denaturation studies described above. Previous
studies of the unfolding and refolding behavior of HSA
using circular dichroism measurements indicated that the
	-helical content of the protein decreased upon thermal
denaturation to 75°C and did not fully recover upon subse-
quent cooling (Wetzel et al., 1980). Thus the 	-helix con-
taining the Trp residue may have been altered to a looser
structure similar to a random coil upon unfolding, and the
new conformation was likely to be unable to refold into the
original form. The fluorescence lifetime characteristics of
the refolded state obtained after chemical denaturation were
effectively identical to those measured for the protein after
recovery from thermal denaturation. This was not expected,
because the spectra of the two recovered proteins are quite
different in terms of wavelength and intensity.
TABLE 3 Fluorescence intensity decay parameters for the Trp residue within HSA and the acrylodan moiety of HSA-Ac as a
function of temperature
Sample 	1 	2 	3 f1* f2 f3 1 (ns) 2 (ns) 3 (ns) 
 (ns)# 2
Tryptophan in HSA
20°C 0.57 0.29 0.14 0.79 0.20 0.01 5.913 3.046 0.231 5.28 1.054
75°C 0.38 0.62 — 0.67 0.33 — 3.251 0.984 — 2.50 1.030
20°C (recovered) 0.42 0.33 0.25 0.77 0.21 0.02 5.628 1.920 0.195 4.72 1.033
Acrylodan in HSA-
Ac
20°C 0.56 0.44 — 0.87 0.13 — 4.137 1.363 — 3.77 1.083
80°C 0.54 0.46 — 0.79 0.21 — 3.327 1.195 — 2.88 1.005
20°C (recovered) 0.64 0.36 — 0.85 0.15 — 4.046 1.269 — 3.62 1.022
*Calculated from Eq. 3.
#Calculated from Eq. 4.
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Table 3 also shows the preexponential terms and fluores-
cence lifetime components obtained for the acrylodan probe
within HSA-Ac at 20°C, after heating to 80°C and after
subsequent recovery to 20°C. These data clearly show that
both lifetime components decrease upon heating; however,
the shorter of the two components decreases by 63%,
whereas the longer component drops by only 18%. Cooling
to 20°C caused the mean lifetime to recover to within a few
percent of the original value; however, there was once again
a significant difference in the value and the contribution of
the short lifetime component, indicating that the environ-
ment within the cybotactic region surrounding the acrylodan
probe did not recover to the initial conditions before heat-
ing. These results are consistent with those for the Trp
residue in HSA, and overall suggest that the protein does not
refold to its native structure after heating beyond the protein
Tun.
Time-resolved anisotropy provided evidence of increased
rotational motion of the acrylodan probe upon heating of the
protein, as shown in Fig. 6. The global reorientation time
was again higher than expected (	55 ns), as was found
during chemical denaturation studies, further supporting the
presence of protein dimers or multimers. Interestingly, both
the global and local rotational correlation times decreased
substantially over the first 10°C increase (20°C to 30°C).
This corresponds to the temperature range for the initial
increase observed in the intensity of the acrylodan label and
the increase in the Trp signal when HSA-Ac was denatured.
This suggests that there may be a pretransition, or perhaps
a local change in the environment of the acrylodan label
(domain separation). However, there appear to be no corre-
sponding changes in steady-state anisotropy. Further in-
creases in temperature up to 90°C caused the global corre-
lation time to decrease until a temperature of 70°C was
reached, at which point a slight increase in 2 was observed.
The most striking change in the time-resolved fluorescence
anisotropy was the significant increase in the contribution
from the local rotational motion, as evidenced by the large
increase in 
1 between 60°C and 80°C, which corresponds
well to the region where the acrylodan intensity reported the
unfolding of domain I.
A model for unfolding of HSA
Based on the results presented above, the following model
for unfolding of HSA can be developed. Based on salicylate
binding studies, it is clear that raising the temperature to
50°C or adding up to 1.0 M of GdHCl causes a complete
loss of protein function, but that this process is almost fully
reversible. Energy transfer results suggest that domains I
and II move apart during this stage, causing slight alter-
ations in the local environments of both the Trp and acry-
lodan residue. This conclusion is based on the observed
changes in emission maximum values for both probes, the
increase in Trp intensity over this range for HSA-Ac (Fig. 2
B), and the slight changes in the time-resolved decay of
intensity and anisotropy for the acrylodan moiety. Increas-
ing the temperature above 60°C or increasing the level of
denaturant to 2.0 M resulted in substantial changes in the
spectroscopic parameters for the Trp residue. Both the in-
tegrated intensity and the steady-state anisotropy of the Trp
FIGURE 6 Time-resolved anisotropy of acrylodan within HSA-Ac dur-
ing thermal denaturation. (A) Fluorescence rotational correlation times for
global (2) and local (1) rotational components. (B) Fractional contribu-
tion of 1 as a function of temperature. (C) Semiangle of probe rotation
obtained during heating of the protein. The error bars on each panel denote
1 standard deviation from at least three discrete measurements.
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residue drop significantly over this range. In the case of
chemical denaturation, this change was accompanied by a
15-nm red shift in the emission maximum, a doubling of the
kq value, and a decrease of 16% in the mean fluorescence
lifetime. For thermal unfolding, the emission maximum did
not shift significantly. However, the fluorescence lifetime
dropped by 53%. Together, these changes indicate a major
structural change for the protein which is consistent with the
unfolding of domain II. The spectroscopic parameters for
the acrylodan probe over this temperature or denaturant
range changed only slightly, with most parameters changing
value by only a few percent. The most notable changes for
acrylodan were the slight decrease in semiangle, which was
accompanied by a 5-nm blue shift in the emission maximum
for the probe. These changes are consistent with a slight
closing of the pocket surrounding the acrylodan moiety, and
may be indicative of an indirect effect of domain II unfold-
ing on the environment of domain I. Salicylate binding
studies indicated that this stage of unfolding was only
partially reversible, in agreement with the altered spectro-
scopic parameters for the Trp residue for the recovered
protein.
Increasing the temperature above 70°C or higher, or the
level of GdHCl to 4.0 M or above, resulted in small changes
in the spectroscopic behavior of the Trp residue, but had a
significant effect on the emission properties of the acrylo-
dan moiety. For example, the integrated intensity and an-
isotropy both decreased substantially between 2.2 M and 5.0
M GdHCl, with corresponding decreases in the mean fluo-
rescence lifetime. For chemical denaturation, a 10-nm red
shift in the emission maximum and a 70% increase in the kq
value of the acrylodan moiety were also observed, with the
semiangle for acrylodan rotation increasing by 9°. Overall,
these changes indicate that the acrylodan moiety becomes
much more solvent exposed and more mobile, consistent
with the unfolding of domain I. In addition, the energy
transfer experiment indicated a significant increase in the
average Trp-to-acrylodan distance, providing further evi-
dence of an overall expansion in the size of the protein.
Salicylate binding experiments indicated that these struc-
tural alterations were only partially reversible. Thus the
unfolding of either domain I or domain II causes a signifi-
cant loss in protein function.
The denaturation experiments indicate that the unfolding
of HSA proceeds by the following scheme:
N ¢O¡
Step 1
EO¡
Step 2
IO¡
Step 3
U (I)
where N is the native form of the protein, E is the expanded
form, I is an intermediate where domain II is unfolded but
domain I is intact, and U is the unfolded protein. The
scheme proposed above is consistent with previous reports,
which show that heating HSA to temperatures less than
60°C results in refolding being fully reversible, whereas
heating to higher temperatures results in a substantial loss of
reversibility for the unfolding transition (Pico, 1997). This
model is also consistent with previous reports that suggest a
multistep unfolding pathway for HSA (Wallevick, 1973;
Chmelik and Kalous, 1982; Pico, 1997). However, our
model is the first to provide detailed insight into the nature
of the various unfolding intermediates, and is the first to
show that unfolding of domain I occurs only after the
unfolding of domain II is complete. Spectroscopic data from
both the Trp and acrylodan probes suggest that the U state
shown in Scheme I is not a fully unfolded random coil, but
rather a partially unfolded or molten globule state. This is
likely the result of intact disulfide bonds within the various
domains, which act to maintain a degree of structure (Lee
and Hirose, 1992). The addition of a disulfide reducing
agent was not attempted, because this would have removed
the acrylodan label from Cys34.
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